Tandamine--a new norepinephrine reuptake inhibitor. Clinical, psychometric and quantitative EEG studies in depressed patients. 1977

B Saletu, and P Krieger, and J Grünberger, and H Schanda, and I Sletten

Tandamine (AY-23,946)- a new norepinephrine reuptake inhibitor with practically no serotonin potentiation, MAO inhibition and anticholinergic activity-was administered in doses from 75 to 200 mg to a group of 20 hospitalized depressed patients. Weekly clinical evaluation including the ECDEU global score. Hamilton score and Zung self-rating score demonstrated a slight improvement which became statistically significant between the 1st and 2nd weeks of therapy. While the 'thymoleptic' properties of the drug were weak, a pronouned 'activating/stimulatory' effect of the drug was noted. Psychometric tests showed an increase in attention, concentration and psychomotor activity as well as an improvement in FPI personality dimensions 'depression' and 'inhibition', while the Taylor anxiety score did not reveal any changes. Digital computer period analysis of the EEG demonstrated, 6 h after oral administration of 50 mg tandamine, a decrease of slow waves, a significant increase of fast activity as well as a significant attenuation of the amplitude variability. Such changes are reminiscent of the pharmaco-EEG profile of psychostimulatory drugs and may represent the neurophysiological correlate for the activating/stimulatory properties of tandamine. Our finding suggest that the well-tolerated drug may be of some benefit for retarded depressions.

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D008297 Male Males
D008347 Manifest Anxiety Scale True-false questionnaire made up of items believed to indicate anxiety, in which the subject answers verbally the statement that describes him. Taylor Manifest Anxiety Scale,Anxiety Scale, Manifest,Anxiety Scales, Manifest,Manifest Anxiety Scales,Scale, Manifest Anxiety,Scales, Manifest Anxiety
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004569 Electroencephalography Recording of electric currents developed in the brain by means of electrodes applied to the scalp, to the surface of the brain, or placed within the substance of the brain. EEG,Electroencephalogram,Electroencephalograms

Related Publications

B Saletu, and P Krieger, and J Grünberger, and H Schanda, and I Sletten
August 2006, The Journal of pharmacology and experimental therapeutics,
B Saletu, and P Krieger, and J Grünberger, and H Schanda, and I Sletten
January 1977, Journal of neural transmission,
B Saletu, and P Krieger, and J Grünberger, and H Schanda, and I Sletten
July 2006, Current opinion in investigational drugs (London, England : 2000),
B Saletu, and P Krieger, and J Grünberger, and H Schanda, and I Sletten
January 2004, Journal of psychiatric practice,
B Saletu, and P Krieger, and J Grünberger, and H Schanda, and I Sletten
January 2004, CNS drug reviews,
B Saletu, and P Krieger, and J Grünberger, and H Schanda, and I Sletten
March 2004, Journal of psychiatric practice,
B Saletu, and P Krieger, and J Grünberger, and H Schanda, and I Sletten
March 1977, Psychopharmacology,
B Saletu, and P Krieger, and J Grünberger, and H Schanda, and I Sletten
December 2000, Clinical pharmacokinetics,
B Saletu, and P Krieger, and J Grünberger, and H Schanda, and I Sletten
December 2005, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
B Saletu, and P Krieger, and J Grünberger, and H Schanda, and I Sletten
October 2020, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
Copied contents to your clipboard!